Epidemiology of Acute Otitis Media Changed From 2006 - 2016
Change in proportion of S. pneumoniae, H. influenzae, M. catarrhalis causing AOM (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - August 7, 2017 Category: Respiratory Medicine Tags: Infections, ENT, Pediatrics, Pharmacy, Pulmonology, Journal, Source Type: news
Novus Therapeutics Announces Change in Management
IRVINE, Calif., July 10, 2017 -- (Healthcare Sales & Marketing Network) -- Novus Therapeutics, Inc. (NASDAQ: NVUS), a pharmaceutical company focusing on the development of ear, nose, and throat (ENT) products, today announced that Jon Kuwahara has joined ... Biopharmaceuticals, Personnel Novus Therapeutics, otitis media, Eustachian tube dysfunction (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 10, 2017 Category: Pharmaceuticals Source Type: news
Mucin Gene Linked to Hearing Loss in Otitis Media With Effusion Mucin Gene Linked to Hearing Loss in Otitis Media With Effusion
Increased expression of the mucin gene MUC5B is associated with hearing loss in children with otitis media with effusion (OME), a new case-control study shows.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 15, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news
NUS researchers create palm-size device for quick, effective treatment of hearing disorder
(National University of Singapore) Researchers from the National University of Singapore have developed a novel handheld device, known as CLiKX, for the treatment of a condition called Otitis Media with Effusion, or 'glue ear,' which is the leading cause of hearing loss and visits to the doctors among children worldwide. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 24, 2017 Category: International Medicine & Public Health Source Type: news
Weigh Risks/Benefits of Tympanostomy Tubes: Researchers Weigh Risks/Benefits of Tympanostomy Tubes: Researchers
In children with chronic otitis media with effusion, tympanostomy tubes improve hearing at one to three months compared with watchful waiting, with no evidence of benefit by 12 to 24 months, a new research review suggests.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - May 17, 2017 Category: Surgery Tags: Internal Medicine News Source Type: news
How Common is α -1-Antitrypsin Deficiency?
Discussion
α-1-Antitrypsin Deficiency (A1AT) is a common single-gene mutation disease that is homozygous recessive. The normal allele is called M and the most common abnormal allele is Z. There are other alleles though. The gene codes for one of the primary protease inhibitors in the serum, thus those who are homozygous for the Z gene are sometimes referred to as “PIZZ” or “PIZ.” α-1-Antitrypsin is found in all body tissues but is especially important in the serum and lung. As noted it is one of the primary neutrophil protease inhibitors in the serum, and acts to neutralize these enzymes...
Source: PediatricEducation.org - April 24, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Antibiotics for AOM in Kids Under 2: Must We Go Long? Antibiotics for AOM in Kids Under 2: Must We Go Long?
A randomized trial answers an important clinical question about the management of acute otitis media in young children.Medscape Pediatrics (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 7, 2017 Category: Allergy & Immunology Tags: Pediatrics Viewpoint Source Type: news
Inhaled Corticosteroids Not Linked to Pneumonia in Children
No increased risk of pneumonia; no link for ICS with risk of pharyngitis, otitis media, sinusitis (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - February 27, 2017 Category: Respiratory Medicine Tags: Family Medicine, Infections, Nursing, Pediatrics, Pharmacy, Pulmonology, Allergy, Journal, Source Type: news
Safety Risks of Baltic Amber Teething Necklaces and Similar Cultural Practices?
Discussion
Amber is fossilized tree resin that is prized for its beautiful colors from deep brown to caramel, yellow, green or even white. It is promoted for its “healing properties” although there is not scientific evidence that supports the many potentiated mechanisms of these properties. One of the most consistent is that amber contains succinic acid which proponents believe is absorbed through the skin and is a pain reliever. Succinic acid was actually first purified from amber in 1546 by a German chemist. Succinic acid in humans is an important part of the Krebs cycle and acts as an important metabolite in...
Source: PediatricEducation.org - February 27, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Your NEJM Group Today: Eosinophilic Otitis Media / CROI 2017 Really Rapid Review / NC Family Medicine Opportunities (FREE)
By the Editors
Here ' s what we chose for you from NEJM Group today:NEJM Clinical Practice Center: Image in clinical medicine: A 50-year-old man presented with a 6-month history … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - February 20, 2017 Category: Primary Care Source Type: news
OtoNexus raises $8m for middle-ear infection tech
OtoNexus Medical Technologies raised $7.9 million to fund development of its ultrasound device used to diagnose middle-ear infections in children and determine if antibiotics are needed for treatment. The Seattle-based company sold nearly $8 million in equity of its $9.2 million offering.
CEO Caitlin Cameron filed a Form D with the Securities & Exchange Commission, writing that the 1st sale date was December 30, 2016.
OtoNexus is developing an air-coupled ultrasound diagnostic device that identifies and characterizes fluid in the middle ear to determine if a physician should prescribe antibiotics. The device uses disp...
Source: Mass Device - January 13, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Funding Roundup Otolaryngology Ear, Nose & Throat Pediatrics Wall Street Beat OtoNexus Medical Technologies Source Type: news
Antibiotics for AOM: 10 Days More Effective Than 5 Antibiotics for AOM: 10 Days More Effective Than 5
A 10-day course of amoxicillin-clavulanate worked better than a 5-day course for children younger than 2 years who had acute otitis media, according to a two-center randomized controlled trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 22, 2016 Category: Consumer Health News Tags: Pediatrics News Source Type: news
Can Short-Course Antibiotics Beat Otitis Media in Kids?
(MedPage Today) -- F. Perry Wilson, MD, examines a randomized trial (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - December 22, 2016 Category: Pediatrics Source Type: news
Treatment of Otitis Media: How Long Is Long Enough? (FREE)
By Deborah Lehman, MD
Dr. Lehman is an associate editor with NEJM Journal Watch Pediatrics and Adolescent Medicine, from which this story was adapted. Full coverage is available to subscribers at the link below.Young children with otitis media … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 21, 2016 Category: Primary Care Source Type: news
Pediapharm wins Health Canada nod for antibiotic, steroid combo ear drop
Pediapharm Inc. (CVE:PDP) said today that it won regulatory approval from Health Canada for its Otixal eye drop solution for the treatment of acute otitis media with tympanostomy tubes in pediatric patients.
The Quebec-based company touts Otixal as the 1st antibiotic and steroid combination ear drop available in single, sterile unit-dose packaging. Otitis media, or middle ear inflammation, is 1 of the most common pediatric infections in Canada, according to Pediapharm. Tympanostomy tubes can be inserted in the eardrum to drain fluid from the middle ear in children with recurrent acute otitis media.
Get the full story at ou...
Source: Mass Device - December 12, 2016 Category: Medical Equipment Authors: Sarah Faulkner Tags: Drug-Device Combinations Otolaryngology Ear, Nose & Throat Pharmaceuticals Regulatory/Clearance Pediapharm Source Type: news
